Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q71387871
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241121000100.0 |
008
|
|
|
241121nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q71387871
|
024
|
|
|
‡a
0000-0001-7051-7871
‡2
orcid
|
024
|
|
|
‡a
7102318545
‡2
scopus
|
035
|
|
|
‡a
(OCoLC)Q71387871
|
100
|
0 |
|
‡a
R Delgado
‡c
researcher
‡9
en
|
400
|
0 |
|
‡a
R Delgado
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's A Mangifera indica L. extract could be used to treat neuropathic pain and implication of mangiferin.
|
670
|
|
|
‡a
Author's A novel multi-target ligand (JM-20) protects mitochondrial integrity, inhibits brain excitatory amino acid release and reduces cerebral ischemia injury in vitro and in vivo.
|
670
|
|
|
‡a
Author's A strong protective action of guttiferone-A, a naturally occurring prenylated benzophenone, against iron-induced neuronal cell damage.
|
670
|
|
|
‡a
Author's An aqueous stem bark extract of Mangifera indica (Vimang) inhibits T cell proliferation and TNF-induced activation of nuclear transcription factor NF-kappaB
|
670
|
|
|
‡a
Author's Anthelminthic and antiallergic activities of Mangifera indica L. stem bark components Vimang and mangiferin.
|
670
|
|
|
‡a
Author's Anti-allodynic Effect of Mangiferin in Rats With Chronic Post-ischemia Pain: A Model of Complex Regional Pain Syndrome Type I
|
670
|
|
|
‡a
Author's Anti-hypernociceptive effect of mangiferin in persistent and neuropathic pain models in rats
|
670
|
|
|
‡a
Author's Antihyperalgesic effects of an aqueous stem bark extract of Mangifera indica L.: role of mangiferin isolated from the extract.
|
670
|
|
|
‡a
Author's Antioxidant and Neuroprotective Effects of KM-34, A Novel Synthetic Catechol, Against Oxidative Stress-Induced Neurotoxicity.
|
670
|
|
|
‡a
Author's Antioxidant effects of JM-20 on rat brain mitochondria and synaptosomes: mitoprotection against Ca²⁺-induced mitochondrial impairment.
|
670
|
|
|
‡a
Author's Ca(2+)-independent nitric oxide synthase activity in human lung after cardiopulmonary bypass.
|
670
|
|
|
‡a
Author's Case series in patients with zoster-associated pain using Mangifera indica L. extract
|
670
|
|
|
‡a
Author's Chlorpromazine inhibits both the constitutive nitric oxide synthase and the induction of nitric oxide synthase after LPS challenge
|
670
|
|
|
‡a
Author's Combination of Mangifera indica L. extract supplementation plus methotrexate in rheumatoid arthritis patients: a pilot study.
|
670
|
|
|
‡a
Author's Dry amorphisation of mangiferin, a poorly water-soluble compound, using mesoporous silica
|
670
|
|
|
‡a
Author's Dual mechanism of mangiferin protection against iron-induced damage to 2-deoxyribose and ascorbate oxidation.
|
670
|
|
|
‡a
Author's Effect of advanced glycosylation end products on the induction of nitric oxide synthase in murine macrophages
|
670
|
|
|
‡a
Author's Effects of a Mangifera indica L. stem bark extract and mangiferin on radiation-induced DNA damage in human lymphocytes and lymphoblastoid cells.
|
670
|
|
|
‡a
Author's Evaluation of genotoxicity and DNA protective effects of mangiferin, a glucosylxanthone isolated from Mangifera indica L. stem bark extract.
|
670
|
|
|
‡a
Author's Fe(III) improves antioxidant and cytoprotecting activities of mangiferin
|
670
|
|
|
‡a
Author's Fe(III) shifts the mitochondria permeability transition-eliciting capacity of mangiferin to protection of organelle
|
670
|
|
|
‡a
Author's Gallic acid indanone and mangiferin xanthone are strong determinants of immunosuppressive anti-tumour effects of Mangifera indica L. bark in MDA-MB231 breast cancer cells.
|
670
|
|
|
‡a
Author's Immunopharmacology 2011: an updated report of clinical achievements and perspectives.
|
670
|
|
|
‡a
Author's In Vitro Neuroprotective and Anti-Inflammatory Activities of Natural and Semi-Synthetic Spirosteroid Analogues.
|
670
|
|
|
‡a
Author's In vivo acute toxicological studies of an antioxidant extract from Mangifera indica L.
|
670
|
|
|
‡a
Author's In vivo acute toxicological studies of an antioxidant extract from Mangifera indica L. (Vimang).
|
670
|
|
|
‡a
Author's Interaction of Vimang (Mangifera indica L. extract) with Fe(III) improves its antioxidant and cytoprotecting activity
|
670
|
|
|
‡a
Author's JM-20, a novel benzodiazepine–dihydropyridine hybrid molecule, protects mitochondria and prevents ischemic insult-mediated neural cell death in vitro.
|
670
|
|
|
‡a
Author's Mangifera indica L.
|
670
|
|
|
‡a
Author's "Mangifera indica L. extract
|
670
|
|
|
‡a
Author's Mangifera indica L. extract and mangiferin modulate cytochrome P450 and UDP-glucuronosyltransferase enzymes in primary cultures of human hepatocytes.
|
670
|
|
|
‡a
Author's Mangifera indica L. extract protects T cells from activation-induced cell death
|
670
|
|
|
‡a
Author's "Mangifera indica L. extract (QF808) reduces ischaemia-induced neuronal loss and oxidative damage in the gerbil brain".
|
670
|
|
|
‡a
Author's Mangifera indica L. extract (Vimang) and its main polyphenol mangiferin prevent mitochondrial oxidative stress in atherosclerosis-prone hypercholesterolemic mouse.
|
670
|
|
|
‡a
Author's Mangifera indica L. extract (Vimang) and mangiferin modulate mouse humoral immune responses.
|
670
|
|
|
‡a
Author's Mangifera indica L. extract (Vimang) and mangiferin reduce the airway inflammation and Th2 cytokines in murine model of allergic asthma
|
670
|
|
|
‡a
Author's Mangifera indica L. extract (Vimang) inhibits Fe2+-citrate-induced lipoperoxidation in isolated rat liver mitochondria.
|
670
|
|
|
‡a
Author's Mangifera indica L. (Vimang) protection against serum oxidative stress in elderly humans.
|
670
|
|
|
‡a
Author's Mangiferin, a natural occurring glucosyl xanthone, increases susceptibility of rat liver mitochondria to calcium-induced permeability transition.
|
670
|
|
|
‡a
Author's Mangiferin, a naturally occurring glucoxilxanthone improves long-term object recognition memory in rats.
|
670
|
|
|
‡a
Author's Modulation of eosinophil generation and migration by Mangifera indica L. extract
|
670
|
|
|
‡a
Author's Modulation of eosinophil generation and migration by Mangifera indica L. extract (Vimang)
|
670
|
|
|
‡a
Author's Modulation of P450 enzymes by Cuban natural products rich in polyphenolic compounds in rat hepatocytes.
|
670
|
|
|
‡a
Author's Modulation of rat macrophage function by the Mangifera indica L. extracts Vimang and mangiferin.
|
670
|
|
|
‡a
Author's Monoclonal antibodies against a 62 kDa proteinase of Trichomonas vaginalis decrease parasite cytoadherence to epithelial cells and confer protection in mice.
|
670
|
|
|
‡a
Author's Monocyte chemotactic protein-1 inhibits the induction of nitric oxide synthase in J774 cells
|
670
|
|
|
‡a
Author's Neuroprotection by JM-20 against oxygen-glucose deprivation in rat hippocampal slices: Involvement of the Akt/GSK-3β pathway.
|
670
|
|
|
‡a
Author's Nitric oxide modulates interleukin-2-induced proliferation in CTLL-2 cells.
|
670
|
|
|
‡a
Author's Pre-emptive anti-hyperalgesic effect of electroacupuncture in carrageenan-induced inflammation: role of nitric oxide.
|
670
|
|
|
‡a
Author's Protective effect of Mangifera indica L. polyphenols on human T lymphocytes against activation-induced cell death
|
670
|
|
|
‡a
Author's Semi-synthetic sapogenin exerts neuroprotective effects by skewing the brain ischemia reperfusion transcriptome towards inflammatory resolution.
|
670
|
|
|
‡a
Author's The effects of JM-20 on the glutamatergic system in synaptic vesicles, synaptosomes and neural cells cultured from rat brain.
|
670
|
|
|
‡a
Author's The paradox of natural products as pharmaceuticals. Experimental evidences of a mango stem bark extract.
|
909
|
|
|
‡a
(orcid) 0000000170517871
‡9
1
|
909
|
|
|
‡a
(scopus) 7102318545
‡9
1
|
919
|
|
|
‡a
protectiveeffectofmangiferaindica50polyphenolsonhumantlymphocytesagainstactivationinducedcelldeath
‡A
Protective effect of Mangifera indica L. polyphenols on human T lymphocytes against activation-induced cell death
‡9
1
|
919
|
|
|
‡a
semisyntheticsapogeninexertsneuroprotectiveeffectsbyskewingthebrainischemiareperfusiontranscriptometowardsinflammatoryresolution
‡A
Semi-synthetic sapogenin exerts neuroprotective effects by skewing the brain ischemia reperfusion transcriptome towards inflammatory resolution.
‡9
1
|
919
|
|
|
‡a
paradoxofnaturalproductsaspharmaceuticalsexperimentalevidencesofamangostembarkextract
‡A
The paradox of natural products as pharmaceuticals. Experimental evidences of a mango stem bark extract.
‡9
1
|
919
|
|
|
‡a
effectsofjm20ontheglutamatergicsysteminsynapticvesiclessynaptosomesandneuralcellsculturedfromratbrain
‡A
The effects of JM-20 on the glutamatergic system in synaptic vesicles, synaptosomes and neural cells cultured from rat brain.
‡9
1
|
919
|
|
|
‡a
mangiferaindica50extractcouldbeusedtotreatneuropathicpainandimplicationofmangiferin
‡A
A Mangifera indica L. extract could be used to treat neuropathic pain and implication of mangiferin.
‡9
1
|
919
|
|
|
‡a
novelmultitargetligandjm20protectsmitochondrialintegrityinhibitsbrainexcitatoryaminoacidreleaseandreducescerebralischemiainjuryinvitroandinvivo
‡A
A novel multi-target ligand (JM-20) protects mitochondrial integrity, inhibits brain excitatory amino acid release and reduces cerebral ischemia injury in vitro and in vivo.
‡9
1
|
919
|
|
|
‡a
strongprotectiveactionofguttiferoneaanaturallyoccurringprenylatedbenzophenoneagainstironinducedneuronalcelldamage
‡A
A strong protective action of guttiferone-A, a naturally occurring prenylated benzophenone, against iron-induced neuronal cell damage.
‡9
1
|
919
|
|
|
‡a
aqueousstembarkextractofmangiferaindicavimanginhibitstcellproliferationandtnfinducedactivationofnucleartranscriptionfactornfkappab
‡A
An aqueous stem bark extract of Mangifera indica (Vimang) inhibits T cell proliferation and TNF-induced activation of nuclear transcription factor NF-kappaB
‡9
1
|
919
|
|
|
‡a
anthelminthicandantiallergicactivitiesofmangiferaindica50stembarkcomponentsvimangandmangiferin
‡A
Anthelminthic and antiallergic activities of Mangifera indica L. stem bark components Vimang and mangiferin.
‡9
1
|
919
|
|
|
‡a
antiallodyniceffectofmangiferininratswithchronicpostischemiapainamodelofcomplexregionalpainsyndrometype1
‡A
Anti-allodynic Effect of Mangiferin in Rats With Chronic Post-ischemia Pain: A Model of Complex Regional Pain Syndrome Type I
‡9
1
|
919
|
|
|
‡a
antihypernociceptiveeffectofmangiferininpersistentandneuropathicpainmodelsinrats
‡A
Anti-hypernociceptive effect of mangiferin in persistent and neuropathic pain models in rats
‡9
1
|
919
|
|
|
‡a
antihyperalgesiceffectsofanaqueousstembarkextractofmangiferaindica50roleofmangiferinisolatedfromtheextract
‡A
Antihyperalgesic effects of an aqueous stem bark extract of Mangifera indica L.: role of mangiferin isolated from the extract.
‡9
1
|
919
|
|
|
‡a
antioxidantandneuroprotectiveeffectsofkm34anovelsyntheticcatecholagainstoxidativestressinducedneurotoxicity
‡A
Antioxidant and Neuroprotective Effects of KM-34, A Novel Synthetic Catechol, Against Oxidative Stress-Induced Neurotoxicity.
‡9
1
|
919
|
|
|
‡a
antioxidanteffectsofjm20onratbrainmitochondriaandsynaptosomesmitoprotectionagainstca2+inducedmitochondrialimpairment
‡A
Antioxidant effects of JM-20 on rat brain mitochondria and synaptosomes: mitoprotection against Ca²⁺-induced mitochondrial impairment.
‡9
1
|
919
|
|
|
‡a
ca2+independentnitricoxidesynthaseactivityinhumanlungaftercardiopulmonarybypass
‡A
Ca(2+)-independent nitric oxide synthase activity in human lung after cardiopulmonary bypass.
‡9
1
|
919
|
|
|
‡a
caseseriesinpatientswithzosterassociatedpainusingmangiferaindica50extract
‡A
Case series in patients with zoster-associated pain using Mangifera indica L. extract
‡9
1
|
919
|
|
|
‡a
chlorpromazineinhibitsboththeconstitutivenitricoxidesynthaseandtheinductionofnitricoxidesynthaseafterlpschallenge
‡A
Chlorpromazine inhibits both the constitutive nitric oxide synthase and the induction of nitric oxide synthase after LPS challenge
‡9
1
|
919
|
|
|
‡a
combinationofmangiferaindica50extractsupplementationplusmethotrexateinrheumatoidarthritispatientsapilotstudy
‡A
Combination of Mangifera indica L. extract supplementation plus methotrexate in rheumatoid arthritis patients: a pilot study.
‡9
1
|
919
|
|
|
‡a
dryamorphisationofmangiferinapoorlywatersolublecompoundusingmesoporoussilica
‡A
Dry amorphisation of mangiferin, a poorly water-soluble compound, using mesoporous silica
‡9
1
|
919
|
|
|
‡a
dualmechanismofmangiferinprotectionagainstironinduceddamageto2deoxyriboseandascorbateoxidation
‡A
Dual mechanism of mangiferin protection against iron-induced damage to 2-deoxyribose and ascorbate oxidation.
‡9
1
|
919
|
|
|
‡a
effectofadvancedglycosylationendproductsontheinductionofnitricoxidesynthaseinmurinemacrophages
‡A
Effect of advanced glycosylation end products on the induction of nitric oxide synthase in murine macrophages
‡9
1
|
919
|
|
|
‡a
effectsofamangiferaindica50stembarkextractandmangiferinonradiationinduceddnadamageinhumanlymphocytesandlymphoblastoidcells
‡A
Effects of a Mangifera indica L. stem bark extract and mangiferin on radiation-induced DNA damage in human lymphocytes and lymphoblastoid cells.
‡9
1
|
919
|
|
|
‡a
evaluationofgenotoxicityanddnaprotectiveeffectsofmangiferinaglucosylxanthoneisolatedfrommangiferaindica50stembarkextract
‡A
Evaluation of genotoxicity and DNA protective effects of mangiferin, a glucosylxanthone isolated from Mangifera indica L. stem bark extract.
‡9
1
|
919
|
|
|
‡a
fe3improvesantioxidantandcytoprotectingactivitiesofmangiferin
‡A
Fe(III) improves antioxidant and cytoprotecting activities of mangiferin
‡9
1
|
919
|
|
|
‡a
fe3shiftsthemitochondriapermeabilitytransitionelicitingcapacityofmangiferintoprotectionoforganelle
‡A
Fe(III) shifts the mitochondria permeability transition-eliciting capacity of mangiferin to protection of organelle
‡9
1
|
919
|
|
|
‡a
gallicacidindanoneandmangiferinxanthonearestrongdeterminantsofimmunosuppressiveantitumoureffectsofmangiferaindica50barkinmdamb231breastcancercells
‡A
Gallic acid indanone and mangiferin xanthone are strong determinants of immunosuppressive anti-tumour effects of Mangifera indica L. bark in MDA-MB231 breast cancer cells.
‡9
1
|
919
|
|
|
‡a
immunopharmacology2011anupdatedreportofclinicalachievementsandperspectives
‡A
Immunopharmacology 2011: an updated report of clinical achievements and perspectives.
‡9
1
|
919
|
|
|
‡a
invitroneuroprotectiveandantiinflammatoryactivitiesofnaturalandsemisyntheticspirosteroidanalogues
‡A
In Vitro Neuroprotective and Anti-Inflammatory Activities of Natural and Semi-Synthetic Spirosteroid Analogues.
‡9
1
|
919
|
|
|
‡a
invivoacutetoxicologicalstudiesofanantioxidantextractfrommangiferaindica50
‡A
In vivo acute toxicological studies of an antioxidant extract from Mangifera indica L.
‡9
1
|
919
|
|
|
‡a
invivoacutetoxicologicalstudiesofanantioxidantextractfrommangiferaindica50vimang
‡A
In vivo acute toxicological studies of an antioxidant extract from Mangifera indica L. (Vimang).
‡9
1
|
919
|
|
|
‡a
interactionofvimangmangiferaindica50extractwithfe3improvesitsantioxidantandcytoprotectingactivity
‡A
Interaction of Vimang (Mangifera indica L. extract) with Fe(III) improves its antioxidant and cytoprotecting activity
‡9
1
|
919
|
|
|
‡a
jm20anovelbenzodiazepinedihydropyridinehybridmoleculeprotectsmitochondriaandpreventsischemicinsultmediatedneuralcelldeathinvitro
‡A
JM-20, a novel benzodiazepine–dihydropyridine hybrid molecule, protects mitochondria and prevents ischemic insult-mediated neural cell death in vitro.
‡9
1
|
919
|
|
|
‡a
mangiferaindica50
‡A
Mangifera indica L.
‡9
1
|
919
|
|
|
‡a
mangiferaindica50extract
‡A
"Mangifera indica L. extract
‡9
1
|
919
|
|
|
‡a
mangiferaindica50extractandmangiferinmodulatecytochromep450andudpglucuronosyltransferaseenzymesinprimaryculturesofhumanhepatocytes
‡A
Mangifera indica L. extract and mangiferin modulate cytochrome P450 and UDP-glucuronosyltransferase enzymes in primary cultures of human hepatocytes.
‡9
1
|
919
|
|
|
‡a
mangiferaindica50extractprotectstcellsfromactivationinducedcelldeath
‡A
Mangifera indica L. extract protects T cells from activation-induced cell death
‡9
1
|
919
|
|
|
‡a
mangiferaindica50extractqf808reducesischaemiainducedneuronallossandoxidativedamageinthegerbilbrain
‡A
"Mangifera indica L. extract (QF808) reduces ischaemia-induced neuronal loss and oxidative damage in the gerbil brain".
‡9
1
|
919
|
|
|
‡a
mangiferaindica50extractvimanganditsmainpolyphenolmangiferinpreventmitochondrialoxidativestressinatherosclerosispronehypercholesterolemicmouse
‡A
Mangifera indica L. extract (Vimang) and its main polyphenol mangiferin prevent mitochondrial oxidative stress in atherosclerosis-prone hypercholesterolemic mouse.
‡9
1
|
919
|
|
|
‡a
mangiferaindica50extractvimangandmangiferinmodulatemousehumoralimmuneresponses
‡A
Mangifera indica L. extract (Vimang) and mangiferin modulate mouse humoral immune responses.
‡9
1
|
919
|
|
|
‡a
mangiferaindica50extractvimangandmangiferinreducetheairwayinflammationandth2cytokinesinmurinemodelofallergicasthma
‡A
Mangifera indica L. extract (Vimang) and mangiferin reduce the airway inflammation and Th2 cytokines in murine model of allergic asthma
‡9
1
|
919
|
|
|
‡a
mangiferaindica50extractvimanginhibitsfe2+citrateinducedlipoperoxidationinisolatedratlivermitochondria
‡A
Mangifera indica L. extract (Vimang) inhibits Fe2+-citrate-induced lipoperoxidation in isolated rat liver mitochondria.
‡9
1
|
919
|
|
|
‡a
mangiferaindica50vimangprotectionagainstserumoxidativestressinelderlyhumans
‡A
Mangifera indica L. (Vimang) protection against serum oxidative stress in elderly humans.
‡9
1
|
919
|
|
|
‡a
mangiferinanaturaloccurringglucosylxanthoneincreasessusceptibilityofratlivermitochondriatocalciuminducedpermeabilitytransition
‡A
Mangiferin, a natural occurring glucosyl xanthone, increases susceptibility of rat liver mitochondria to calcium-induced permeability transition.
‡9
1
|
919
|
|
|
‡a
mangiferinanaturallyoccurringglucoxilxanthoneimproveslongtermobjectrecognitionmemoryinrats
‡A
Mangiferin, a naturally occurring glucoxilxanthone improves long-term object recognition memory in rats.
‡9
1
|
919
|
|
|
‡a
modulationofeosinophilgenerationandmigrationbymangiferaindica50extract
‡A
Modulation of eosinophil generation and migration by Mangifera indica L. extract
‡9
1
|
919
|
|
|
‡a
modulationofeosinophilgenerationandmigrationbymangiferaindica50extractvimang
‡A
Modulation of eosinophil generation and migration by Mangifera indica L. extract (Vimang)
‡9
1
|
919
|
|
|
‡a
modulationofp450enzymesbycubannaturalproductsrichinpolyphenoliccompoundsinrathepatocytes
‡A
Modulation of P450 enzymes by Cuban natural products rich in polyphenolic compounds in rat hepatocytes.
‡9
1
|
919
|
|
|
‡a
modulationofratmacrophagefunctionbythemangiferaindica50extractsvimangandmangiferin
‡A
Modulation of rat macrophage function by the Mangifera indica L. extracts Vimang and mangiferin.
‡9
1
|
919
|
|
|
‡a
monoclonalantibodiesagainsta62kdaproteinaseoftrichomonasvaginalisdecreaseparasitecytoadherencetoepithelialcellsandconferprotectioninmice
‡A
Monoclonal antibodies against a 62 kDa proteinase of Trichomonas vaginalis decrease parasite cytoadherence to epithelial cells and confer protection in mice.
‡9
1
|
919
|
|
|
‡a
monocytechemotacticprotein1inhibitstheinductionofnitricoxidesynthaseinj774cells
‡A
Monocyte chemotactic protein-1 inhibits the induction of nitric oxide synthase in J774 cells
‡9
1
|
919
|
|
|
‡a
neuroprotectionbyjm20againstoxygenglucosedeprivationinrathippocampalslicesinvolvementoftheaktgsk3βpathway
‡A
Neuroprotection by JM-20 against oxygen-glucose deprivation in rat hippocampal slices: Involvement of the Akt/GSK-3β pathway.
‡9
1
|
919
|
|
|
‡a
nitricoxidemodulatesinterleukin2inducedproliferationinctll2cells
‡A
Nitric oxide modulates interleukin-2-induced proliferation in CTLL-2 cells.
‡9
1
|
919
|
|
|
‡a
preemptiveantihyperalgesiceffectofelectroacupunctureincarrageenaninducedinflammationroleofnitricoxide
‡A
Pre-emptive anti-hyperalgesic effect of electroacupuncture in carrageenan-induced inflammation: role of nitric oxide.
‡9
1
|
996
|
|
|
‡2
BNCHL|10000000000000000266065
|
996
|
|
|
‡2
DNB|132497239
|
996
|
|
|
‡2
BNE|XX819283
|
996
|
|
|
‡2
DNB|1056594276
|
996
|
|
|
‡2
BNE|XX1013883
|
996
|
|
|
‡2
DNB|1220641022
|
996
|
|
|
‡2
DNB|123727351X
|
996
|
|
|
‡2
DNB|121943259
|
996
|
|
|
‡2
SUDOC|233580719
|
996
|
|
|
‡2
BNE|XX4883786
|
996
|
|
|
‡2
RERO|A000041006
|
996
|
|
|
‡2
LC|n 97077598
|
996
|
|
|
‡2
BNCHL|10000000000000000189181
|
996
|
|
|
‡2
BNE|XX5437672
|
996
|
|
|
‡2
ISNI|0000000034906899
|
996
|
|
|
‡2
CAOONL|ncf11060357
|
996
|
|
|
‡2
BNC|981058521046206706
|
996
|
|
|
‡2
PLWABN|9810551213705606
|
996
|
|
|
‡2
LC|no2006090204
|
996
|
|
|
‡2
PTBNP|239583
|
996
|
|
|
‡2
JPG|500120272
|
996
|
|
|
‡2
BLBNB|000315655
|
996
|
|
|
‡2
LC|no2017113139
|
996
|
|
|
‡2
NUKAT|n 2012241158
|
996
|
|
|
‡2
BNF|17140446
|
996
|
|
|
‡2
BNF|16545593
|
996
|
|
|
‡2
BNE|XX1393738
|
996
|
|
|
‡2
BNE|XX898863
|
996
|
|
|
‡2
DNB|1057373443
|
996
|
|
|
‡2
BNF|16720304
|
996
|
|
|
‡2
PLWABN|9812815271905606
|
996
|
|
|
‡2
DNB|143737813
|
996
|
|
|
‡2
LC|no 00080898
|
996
|
|
|
‡2
LC|nr 96021884
|
996
|
|
|
‡2
SUDOC|147501105
|
996
|
|
|
‡2
BNE|XX1677447
|
996
|
|
|
‡2
SUDOC|136751164
|
996
|
|
|
‡2
ISNI|0000000078268876
|
996
|
|
|
‡2
DNB|1018798048
|
996
|
|
|
‡2
LC|n 50047636
|
996
|
|
|
‡2
SZ|123727351X
|
996
|
|
|
‡2
SUDOC|179352288
|
996
|
|
|
‡2
SUDOC|200695282
|
996
|
|
|
‡2
DNB|1056388447
|
996
|
|
|
‡2
LC|no2022006099
|
996
|
|
|
‡2
DNB|1157267661
|
996
|
|
|
‡2
LC|no2014042466
|
996
|
|
|
‡2
SUDOC|185005411
|
996
|
|
|
‡2
ISNI|0000000043505253
|
996
|
|
|
‡2
ISNI|0000000067874715
|
996
|
|
|
‡2
ISNI|000000003129484X
|
996
|
|
|
‡2
LC|n 2017065830
|
996
|
|
|
‡2
LIH|LNB:V-33356;=BG
|
996
|
|
|
‡2
BIBSYS|5100489
|
996
|
|
|
‡2
PLWABN|9810675414205606
|
996
|
|
|
‡2
PTBNP|552802
|
996
|
|
|
‡2
LC|no2021030321
|
996
|
|
|
‡2
BNE|XX1504474
|
996
|
|
|
‡2
NUKAT|n 2010077797
|
996
|
|
|
‡2
BLBNB|000346372
|
996
|
|
|
‡2
BNE|XX4848367
|
996
|
|
|
‡2
NUKAT|n 2009089180
|
996
|
|
|
‡2
CAOONL|ncf11778561
|
996
|
|
|
‡2
J9U|987007407334505171
|
996
|
|
|
‡2
LC|n 2006090811
|
996
|
|
|
‡2
DNB|1235846873
|
996
|
|
|
‡2
CAOONL|ncf12130196
|
996
|
|
|
‡2
J9U|987007448814605171
|
996
|
|
|
‡2
BNC|981058517849706706
|
996
|
|
|
‡2
BNE|XX1248199
|
996
|
|
|
‡2
DNB|1191801829
|
996
|
|
|
‡2
J9U|987007324292405171
|
996
|
|
|
‡2
PTBNP|71572
|
996
|
|
|
‡2
LC|n 93019901
|
996
|
|
|
‡2
DNB|170112314
|
996
|
|
|
‡2
BIBSYS|99033830
|
996
|
|
|
‡2
NUKAT|n 2003070153
|
996
|
|
|
‡2
RERO|A011710350
|
996
|
|
|
‡2
LC|no2017137594
|
996
|
|
|
‡2
SUDOC|181140918
|
996
|
|
|
‡2
ISNI|000000003767929X
|
996
|
|
|
‡2
LC|no2002009461
|
996
|
|
|
‡2
SUDOC|174352611
|
996
|
|
|
‡2
BNC|981058611182406706
|
996
|
|
|
‡2
DNB|105734284X
|
996
|
|
|
‡2
DNB|135261457
|
996
|
|
|
‡2
BIBSYS|14050200
|
996
|
|
|
‡2
NUKAT|n 2010135313
|
996
|
|
|
‡2
CAOONL|ncf11414089
|
996
|
|
|
‡2
CAOONL|ncf11628125
|
996
|
|
|
‡2
SUDOC|159018560
|
996
|
|
|
‡2
SUDOC|149965826
|
996
|
|
|
‡2
J9U|987007335479505171
|
996
|
|
|
‡2
BNE|XX864125
|
996
|
|
|
‡2
ISNI|0000000118199511
|
996
|
|
|
‡2
BNC|981060950473106706
|
996
|
|
|
‡2
ISNI|0000000456816850
|
996
|
|
|
‡2
BNE|XX1798361
|
996
|
|
|
‡2
BNE|XX997212
|
996
|
|
|
‡2
BNF|16617684
|
996
|
|
|
‡2
ISNI|0000000117287624
|
996
|
|
|
‡2
BNE|XX4444891
|
996
|
|
|
‡2
LC|no2020013064
|
996
|
|
|
‡2
ISNI|0000000018895800
|
996
|
|
|
‡2
ISNI|0000000069212950
|
996
|
|
|
‡2
LC|no2024029998
|
996
|
|
|
‡2
DNB|1214448887
|
996
|
|
|
‡2
ISNI|000000011959023X
|
996
|
|
|
‡2
NII|DA16686454
|
996
|
|
|
‡2
BNE|XX4838740
|
996
|
|
|
‡2
LC|no2024029106
|
996
|
|
|
‡2
BIBSYS|3121198
|
996
|
|
|
‡2
BNCHL|10000000000000000267874
|
996
|
|
|
‡2
BNE|XX1087907
|
996
|
|
|
‡2
BNE|XX5073130
|
996
|
|
|
‡2
NUKAT|n 2005071723
|
996
|
|
|
‡2
BNE|XX1721092
|
996
|
|
|
‡2
BNE|XX1664416
|
996
|
|
|
‡2
ISNI|0000000038089822
|
996
|
|
|
‡2
DNB|121377024
|
996
|
|
|
‡2
LC|no2009139049
|
996
|
|
|
‡2
DBC|87097968684226
|
996
|
|
|
‡2
J9U|987007374377905171
|
996
|
|
|
‡2
ISNI|0000000457761150
|
996
|
|
|
‡2
SUDOC|231938160
|
996
|
|
|
‡2
NUKAT|n 2011045835
|
996
|
|
|
‡2
RERO|A005554605
|
996
|
|
|
‡2
DNB|1057044814
|
996
|
|
|
‡2
ISNI|0000000059266584
|
996
|
|
|
‡2
DNB|138655316
|
996
|
|
|
‡2
SELIBR|dtvxn1pxbqkgbxhj
|
996
|
|
|
‡2
ISNI|0000000049140953
|
996
|
|
|
‡2
ISNI|0000000060399376
|
996
|
|
|
‡2
LC|nb2009014627
|
996
|
|
|
‡2
SUDOC|101677790
|
996
|
|
|
‡2
PTBNP|1573012
|
996
|
|
|
‡2
BIBSYS|90650128
|
996
|
|
|
‡2
LC|nr2004001158
|
996
|
|
|
‡2
LC|no2013118771
|
996
|
|
|
‡2
LC|no 98074009
|
996
|
|
|
‡2
BNCHL|10000000000000000203819
|
996
|
|
|
‡2
DNB|171366530
|
996
|
|
|
‡2
SUDOC|249237830
|
996
|
|
|
‡2
SUDOC|146246837
|
996
|
|
|
‡2
ISNI|0000000509099737
|
996
|
|
|
‡2
BNCHL|10000000000000000259988
|
996
|
|
|
‡2
PLWABN|9810671375405606
|
996
|
|
|
‡2
ISNI|0000000439812233
|
996
|
|
|
‡2
SUDOC|082030855
|
996
|
|
|
‡2
BIBSYS|11022196
|
996
|
|
|
‡2
BNE|XX1412272
|
996
|
|
|
‡2
J9U|987007340066005171
|
996
|
|
|
‡2
NYNYRILM|269509
|
996
|
|
|
‡2
ISNI|0000000045214687
|
996
|
|
|
‡2
DNB|171725514
|
996
|
|
|
‡2
LC|no2023098467
|
996
|
|
|
‡2
SUDOC|116495901
|
996
|
|
|
‡2
BNC|981060927760306706
|
996
|
|
|
‡2
BNC|981058608585206706
|
996
|
|
|
‡2
ISNI|0000000080835964
|
996
|
|
|
‡2
BNC|981058518595206706
|
996
|
|
|
‡2
LC|no2010028452
|
996
|
|
|
‡2
DNB|1113671432
|
996
|
|
|
‡2
BNC|981058526313806706
|
996
|
|
|
‡2
DNB|1271126176
|
996
|
|
|
‡2
BNE|XX906886
|
996
|
|
|
‡2
BNE|XX876560
|
996
|
|
|
‡2
LC|n 2016011339
|
996
|
|
|
‡2
NUKAT|n 2020214273
|
996
|
|
|
‡2
LC|n 88021298
|
996
|
|
|
‡2
PTBNP|1806328
|
996
|
|
|
‡2
PTBNP|43366
|
996
|
|
|
‡2
CAOONL|ncf11165838
|
996
|
|
|
‡2
ISNI|0000000071525569
|
996
|
|
|
‡2
BNE|XX5573189
|
996
|
|
|
‡2
BNE|XX5206388
|
996
|
|
|
‡2
J9U|987007260321805171
|
996
|
|
|
‡2
ISNI|0000000029452028
|
996
|
|
|
‡2
ISNI|0000000501480269
|
996
|
|
|
‡2
BNE|XX1607154
|
996
|
|
|
‡2
BNE|XX1454257
|
996
|
|
|
‡2
LC|ns2023001364
|
996
|
|
|
‡2
DNB|1141602954
|
996
|
|
|
‡2
BNCHL|10000000000000000111089
|
996
|
|
|
‡2
RERO|A006074293
|
996
|
|
|
‡2
PLWABN|9810668725705606
|
996
|
|
|
‡2
ISNI|0000000116964021
|
996
|
|
|
‡2
SUDOC|22151838X
|
996
|
|
|
‡2
ISNI|000000005242261X
|
996
|
|
|
‡2
LC|n 85051035
|
996
|
|
|
‡2
ISNI|0000000060843019
|
996
|
|
|
‡2
ISNI|0000000060540827
|
996
|
|
|
‡2
SUDOC|069261342
|
996
|
|
|
‡2
DNB|1057122246
|
996
|
|
|
‡2
SUDOC|110195299
|
996
|
|
|
‡2
LC|n 81120400
|
996
|
|
|
‡2
LC|n 97030224
|
996
|
|
|
‡2
LC|no2022035572
|
996
|
|
|
‡2
LC|nr 98001872
|
996
|
|
|
‡2
BNE|XX5450882
|
996
|
|
|
‡2
PTBNP|1583142
|
996
|
|
|
‡2
PTBNP|1842312
|
996
|
|
|
‡2
LC|no2023008158
|
996
|
|
|
‡2
NTA|242259634
|
996
|
|
|
‡2
ISNI|0000000069420813
|
996
|
|
|
‡2
ISNI|0000000119764228
|
996
|
|
|
‡2
BNF|11887235
|
996
|
|
|
‡2
BNE|XX1089534
|
996
|
|
|
‡2
BNE|XX1508342
|
996
|
|
|
‡2
ISNI|0000000067484645
|
996
|
|
|
‡2
ISNI|0000000071316150
|
996
|
|
|
‡2
BNE|XX889614
|
996
|
|
|
‡2
BNCHL|10000000000000000171005
|
996
|
|
|
‡2
RERO|A024375221
|
996
|
|
|
‡2
ISNI|0000000059199297
|
996
|
|
|
‡2
LC|n 2021048121
|
996
|
|
|
‡2
LC|n 98002087
|
996
|
|
|
‡2
LC|no 98041012
|
996
|
|
|
‡2
DNB|134554299
|
996
|
|
|
‡2
RERO|A017944146
|
996
|
|
|
‡2
ISNI|0000000060183962
|
996
|
|
|
‡2
ISNI|0000000037455026
|
996
|
|
|
‡2
SZ|1172846871
|
996
|
|
|
‡2
ISNI|0000000077031973
|
996
|
|
|
‡2
LC|no2008116881
|
996
|
|
|
‡2
SUDOC|113998414
|
996
|
|
|
‡2
BNE|XX1153214
|
996
|
|
|
‡2
SUDOC|165271302
|
996
|
|
|
‡2
J9U|987007421484505171
|
996
|
|
|
‡2
SUDOC|033205892
|
996
|
|
|
‡2
ISNI|0000000120420107
|
996
|
|
|
‡2
LC|n 97014912
|
996
|
|
|
‡2
PTBNP|1696115
|
996
|
|
|
‡2
NII|DA02688688
|
996
|
|
|
‡2
DNB|1056507314
|
996
|
|
|
‡2
LC|n 2008081859
|
996
|
|
|
‡2
NTA|070807655
|
996
|
|
|
‡2
LC|n 93028653
|
996
|
|
|
‡2
ISNI|0000000059375393
|
996
|
|
|
‡2
BNCHL|10000000000000000290332
|
996
|
|
|
‡2
BNE|XX4955867
|
996
|
|
|
‡2
ISNI|0000000081003713
|
996
|
|
|
‡2
ISNI|0000000053118003
|
996
|
|
|
‡2
LC|n 87145509
|
996
|
|
|
‡2
BNF|17759190
|
996
|
|
|
‡2
JPG|500108420
|
996
|
|
|
‡2
DNB|1218103817
|
996
|
|
|
‡2
BNE|XX5526589
|
996
|
|
|
‡2
DNB|119831334X
|
996
|
|
|
‡2
BNE|XX983530
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|